Vaxart Share Price Today
(NASDAQ: VXRT)

Name: Vaxart Share Price Today (NASDAQ: VXRT) - Vaxart Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Vaxart share price is $0.47 & ₹40.88 as on 6 Mar 2025, 2.30 'hrs' IST

$0.47

Market is closed - opens 8 PM, 06 Mar 2025

View live Vaxart share price in Dollar and Rupees. Guide to invest in Vaxart stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Vaxart, along with analyst recommendations, forecasts, and comprehensive financials.

Vaxart share price movements

Today's Low: $0.47
Today's High: $0.49
$0.47
1.06%
Downside
Day's Volatility :5.12%
Upside
4.1%
52 Weeks Low: $0.45
52 Weeks High: $1.41
$0.47
4.26%
Downside
52 Weeks Volatility :68.09%
Upside
66.67%

Vaxart (VXRT) Returns

Period	Vaxart Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-17.77%	2.1%	0.0%
6 Months	-46.57%	-4.1%	0.0%
1 Year	-60.79%	2.2%	0.0%
3 Years	-89.13%	11.8%	-11.6%

Vaxart (VXRT) Key Statistics

in dollars & INR

Previous Close	$0.4705
Open	$0.4722
Today's High	$0.4901
Today's Low	$0.465
Market Capitalization	$107.0M
Today's Volume	$255.9K
52 Week High	$1.41
52 Week Low	$0.45
Revenue TTM	$16.8M
EBITDA	$-62.8M
Earnings Per Share (EPS)	$-0.4
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-103.37%

How to invest in Vaxart Stock (VXRT) from India?

It is very easy for Indian residents to invest directly in Vaxart from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Vaxart stock in both Indian Rupees (INR) and US Dollars (USD). Search for Vaxart or VXRT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Vaxart or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Vaxart shares which would translate to 1.850 fractional shares of Vaxart as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Vaxart, in just a few clicks!

Returns in Vaxart (VXRT) for Indian investors in Rupees

The Vaxart stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Vaxart investment value today

Current value as on today

₹44,129

Returns

₹55,871

(-55.87%)

Returns from Vaxart Stock

₹60,833 (-60.83%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Vaxart (VXRT)

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Vaxart Stock from India on INDmoney has increased by 6% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Vaxart

Sio Capital Management, LLC
5.06%
Vanguard Group Inc
4.43%
Millennium Management LLC
1.31%
Geode Capital Management, LLC
1.14%
BlackRock Inc
0.88%
SILVERARC CAPITAL MANAGEMENT, LLC
0.47%

Analyst Recommendation on Vaxart

Buy

88%Buy

11%Hold

0%Sell

Based on 9 Wall street analysts offering stock ratings for Vaxart(by analysts ranked 0 to 5 stars)

Based on 9 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Vaxart Stock (VXRT)

What analysts predicted

Upside of 928.36%

Target:

$4.83

Current:

$0.47

Insights on Vaxart Stock (Ticker Symbol: VXRT)

Price Movement
In the last 1 month, VXRT stock has moved down by -38.5%
VXRT vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 123.4%
VXRT vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 137.0%
Price to Sales
ForVXRT every $1 of sales, investors are willing to pay $5.1, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

VXRT Vaxart Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$4.2M	↓ 53.27%
Net Income	$-18.0M	↓ 38.75%
Net Profit Margin	-432.96%	↓ 102.62%

	FY19	Y/Y Change
Revenue	$9.9M	↑ 137.12%
Net Income	$-18.6M	↑ 3.54%
Net Profit Margin	-189.06%	↑ 243.9%

	FY20	Y/Y Change
Revenue	$4.0M	↓ 58.97%
Net Income	$-32.2M	↑ 72.81%
Net Profit Margin	-796.34%	↓ 607.28%

	FY21	Y/Y Change
Revenue	$892.0K	↓ 77.95%
Net Income	$-70.5M	↑ 118.72%
Net Profit Margin	-7.9K%	↓ 7103.88%

	FY22	Y/Y Change
Revenue	$107.0K	↓ 88.0%
Net Income	$-107.8M	↑ 52.91%
Net Profit Margin	-100.7K%	↓ 92808.19%

	FY23	Y/Y Change
Revenue	$7.4M	↑ 6796.26%
Net Income	$-82.5M	↓ 23.47%
Net Profit Margin	-1.1K%	↑ 99590.85%

	Q2 FY23	Q/Q Change
Revenue	$1.4M	↑ 101.19%
Net Income	$-22.6M	↓ 10.3%
Net Profit Margin	-1.7K%	↑ 2063.91%

	Q3 FY23	Q/Q Change
Revenue	$446.0K	↓ 67.16%
Net Income	$-17.4M	↓ 22.84%
Net Profit Margin	-3.9K%	↓ 2240.82%

	Q4 FY23	Q/Q Change
Revenue	$3.2M	↑ 627.58%
Net Income	$-17.4M	↓ 0.14%
Net Profit Margin	-535.44%	↑ 3365.91%

	Q1 FY24	Q/Q Change
Revenue	$2.2M	↓ 32.79%
Net Income	$-24.4M	↑ 40.53%
Net Profit Margin	-1.1K%	↓ 584.09%

	Q2 FY24	Q/Q Change
Revenue	$6.4M	↑ 193.49%
Net Income	$-16.5M	↓ 32.56%
Net Profit Margin	-257.24%	↑ 862.29%

	Q3 FY24	Q/Q Change
Revenue	$4.9M	↓ 22.93%
Net Income	$-14.1M	↓ 14.49%
Net Profit Margin	-285.42%	↓ 28.18%

	FY18	Y/Y Change
Profit	$4.2M	↓ 53.27%

	FY19	Y/Y Change
Profit	$-4.7M	↓ 212.48%

	FY20	Y/Y Change
Profit	$-15.8M	↑ 238.11%

	FY21	Y/Y Change
Profit	$-47.9M	↑ 202.57%

	FY22	Y/Y Change
Profit	$-3.2M	↓ 93.4%

	FY23	Y/Y Change
Profit	$-60.8M	↑ 1822.88%

	Q2 FY23	Q/Q Change
Profit	$231.0K	↓ 157.46%

	Q3 FY23	Q/Q Change
Profit	$-754.0K	↓ 426.41%

	Q4 FY23	Q/Q Change
Profit	$2.0M	↓ 371.22%

	Q1 FY24	Q/Q Change
Profit	$1.1M	↓ 47.14%

	Q2 FY24	Q/Q Change
Profit	$-11.1M	↓ 1124.88%

	Q3 FY24	Q/Q Change
Profit	$4.9M	↓ 144.53%

	FY18	Y/Y Change
Operating Cash Flow	$-14.5M	↓ 51.51%
Investing Cash Flow	$26.2M	↑ 723.76%
Financing Cash Flow	$-1.7M	↑ 332.25%

	FY19	Y/Y Change
Operating Cash Flow	$-13.1M	↓ 10.02%
Investing Cash Flow	$-850.0K	↓ 103.24%
Financing Cash Flow	$16.0M	↓ 1023.08%

	FY20	Y/Y Change
Operating Cash Flow	$-23.8M	↑ 81.44%
Investing Cash Flow	$-1.2M	↑ 43.53%
Financing Cash Flow	$138.3M	↑ 766.63%

	FY21	Y/Y Change
Operating Cash Flow	$-59.8M	↑ 151.92%
Investing Cash Flow	$-49.1M	↑ 3924.34%
Financing Cash Flow	$125.8M	↓ 9.04%

	FY22	Y/Y Change
Operating Cash Flow	$-94.8M	↑ 58.41%
Investing Cash Flow	$-20.4M	↓ 58.42%
Financing Cash Flow	$17.5M	↓ 86.12%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-17.5M	↓ 28.57%
Investing Cash Flow	$-1.6M	↓ 106.22%
Financing Cash Flow	$13.9M	↑ 878.66%

Vaxart Technicals Summary

Sell

Neutral

Buy

Vaxart is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Vaxart (VXRT) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Vaxart Inc	-33.06%	-46.57%	-60.79%	-89.13%	-82.95%
Regeneron Pharmaceuticals, Inc.	1.3%	-41.29%	-30.51%	9.2%	42.38%
Beone Medicines Ltd	15.19%	34.31%	61.3%	43.16%	68.1%
Vertex Pharmaceuticals Incorporated	3.37%	3.77%	18.06%	106.43%	121.36%
Alnylam Pharmaceuticals, Inc.	-11.52%	-3.4%	62.32%	49.04%	120.93%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Vaxart Inc	NA	NA	NA	-0.4	-1.03	-0.33	NA	0.3
Regeneron Pharmaceuticals, Inc.	17.85	17.85	1.03	43.09	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.43	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.33	18.07	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.57	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Vaxart Inc	Buy	$107.0M	-82.95%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$74.9B	42.38%	17.85	31.07%
Beone Medicines Ltd	NA	$28.5B	68.1%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$124.1B	121.36%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$31.5B	120.93%	NA	-12.37%

About Vaxart

Vaxart, Inc., a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, a bivalent oral tablet vaccine in Phase 2 clinical trial for the GI.1 and GII.4 norovirus strains; coronavirus vaccine, which is in Phase 2 clinical trial, for the treatment of SARS-CoV-2 infection; seasonal influenza vaccine, which is in Phase 2 clinical trial, to treat H1 influenza infection; and human papillomavirus therapeutic vaccine, which is in preclinical stage, that targets HPV-16 and HPV-18 for cervical cancers and precancerous cervical lesions. It has a license agreement with Altesa Biosciences, Inc. to develop and commercialize Vapendavir, a capsid-binding broad-spectrum antiviral. Vaxart, Inc. is headquartered in South San Francisco, California.

Organization	Vaxart
Employees	109
CEO	Mr. Steven Lo
Industry	Health Technology

Management People of Vaxart

Name	Title
Dr. Sean N. Tucker Ph.D.	Senior VP & Chief Scientific Officer
Dr. James F. Cummings M.D.	Chief Medical Officer
Mr. Steven Lo	President, CEO & Director
Mr. Phillip Eric Lee	CFO, Principal Financial Officer & Principal Accounting Officer
Dr. Raymond D. Stapleton Jr., Ph.D.	Chief Technology Officer
Mr. Edward B. Berg	Senior VP & General Counsel
Ms. Shaily Jaini Garg	Senior Vice President of Clinical Development & Project Management
Dr. Rajesh Kapoor Ph.D.	Senior Vice President of Quality

Important FAQs about investing in VXRT Stock from India :

What is Vaxart share price today?

Vaxart share price today stands at $0.47, Open: $0.47 ; Previous Close: $0.47 ; High: $0.49 ; Low: $0.47 ; 52 Week High: $1.41 ; 52 Week Low: $0.45.

The stock opens at $0.47, after a previous close of $0.47. The stock reached a daily high of $0.49 and a low of $0.47, with a 52-week high of $1.41 and a 52-week low of $0.45.

Can Indians buy Vaxart shares?

Yes, Indians can invest in the Vaxart (VXRT) from India.

With INDmoney, you can buy Vaxart at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Vaxart at zero transaction cost.

How can I buy Vaxart shares from India?

It is very easy to buy Vaxart from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Vaxart (VXRT) be purchased?

Yes, you can buy fractional shares of Vaxart with INDmoney app.

What are the documents required to start investing in Vaxart stocks?

To start investing in Vaxart, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.